<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25337" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Embryology, Mullerian Ducts (Paramesonephric Ducts)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wilson</surname>
            <given-names>Danielle</given-names>
          </name>
          <aff>University of Texas Health Science Center at Houston</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bordoni</surname>
            <given-names>Bruno</given-names>
          </name>
          <aff>Foundation Don Carlo Gnocchi IRCCS</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Danielle Wilson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bruno Bordoni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25337.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The M&#x000fc;llerian, or paramesonephric, ducts are&#x000a0;structures that are critical in the development of the internal genital portions of the female&#x000a0;reproductive system. The first observation of this formation was by JP&#x000a0;M&#x000fc;ller in 1830. The&#x000a0;M&#x000fc;llerian ducts&#x000a0;will ultimately form&#x000a0;the uterine or fallopian tubes, uterus, cervix, and proximal&#x000a0;third of the vagina in females. Initially, the M&#x000fc;llerian ducts are present in both sexes and appear as paired channels extending inferiorly along the lateral aspect of the embryo to the urogenital sinus at its sinus tubercle. These ducts typically regress in males under the influence of Anti-M&#x000fc;llerian Hormone (AMH), also known&#x000a0;as&#x000a0;M&#x000fc;llerian Inhibiting Substance (MIS),&#x000a0;M&#x000fc;llerian Inhibiting&#x000a0;Hormone (MIH),&#x000a0;or Anti-M&#x000fc;llerian Factor (AMF). Anti-M&#x000fc;llerian hormone is produced by the Sertoli cells of the testes and inhibits the development of the female internal genitalia.</p>
        <p>Without the influence of AMH, the M&#x000fc;llerian or paramesonephric ducts will develop&#x000a0;in either sex into&#x000a0;the uterus, uterine tubes, cervix, and the&#x000a0;superior 1/3 of the vagina. The&#x000a0;incipient&#x000a0;development of the M&#x000fc;llerian ducts in both sexes and the development along a female path after sex determination is thought to be highly regulated by different signaling molecules and gene expression, including&#x000a0;<italic toggle="yes">EMX2, HOXA13, PAX2, LIM1</italic>, and <italic toggle="yes">WNT</italic>. Disruption of these&#x000a0;mechanisms can result in various developmental anomalies of the female internal genitalia, such as agenesis of the uterus or formation of a unicornuate, bicornuate, didelphic, septate,&#x000a0;or arcuate uterus.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r2">[2]</xref></p>
      </sec>
      <sec id="article-25337.s2" sec-type="Development">
        <title>Development</title>
        <p>There are three phases of the development of the M&#x000fc;llerian ducts:&#x000a0;initiation, invagination, and elongation<xref ref-type="bibr" rid="article-25337.r3">[3]</xref>. Throughout the initial phases of development, the&#x000a0;M&#x000fc;llerian ducts are closely associated with the mesonephric or Wolffian ducts. Early in development, both males and females&#x000a0;have two&#x000a0;pairs&#x000a0;of M&#x000fc;llerian and Wolffian ducts that serve important roles in developing the internal genitalia. In&#x000a0;embryos with XY chromosomes, the Wolffian ducts&#x000a0;typically&#x000a0;give rise to the male reproductive tract, including the&#x000a0;ductus deferentes, epididymides, and seminal vesicles. In embryos with XX chromosomes,&#x000a0;the Wolffian ducts typically regress due to the lack of testis-produced androgens and&#x000a0;may&#x000a0;be actively promoted by COUP-TFII based on mouse studies.<xref ref-type="bibr" rid="article-25337.r4">[4]</xref>&#x000a0;In embryos with XY chromosomes, the M&#x000fc;llerian ducts&#x000a0;typically&#x000a0;regress due to the presence of the testis-derived anti-M&#x000fc;llerian hormone (AMH) produced by the Sertoli cells of the functioning testis <italic toggle="yes">in utero</italic>. Without the presence of both testis-derived testosterone and AMH, the&#x000a0;M&#x000fc;llerian ducts continue to develop into the female internal genitalia and produce the fallopian tubes, uterus, cervix, and upper&#x000a0;third of the vagina.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r3">[3]</xref><xref ref-type="bibr" rid="article-25337.r5">[5]</xref></p>
        <p>Both the&#x000a0;M&#x000fc;llerian and Wolffian ducts develop on the mesonephric kidneys.&#x000a0;M&#x000fc;llerian duct precursors are present on the mesonephros in a specific region of the coelomic epithelium referred to as the&#x000a0;M&#x000fc;llerian ridge. The specification of this region is the first step of&#x000a0;M&#x000fc;llerian duct development and begins at the cranial pole of the mesonephric kidney. The&#x000a0;M&#x000fc;llerian ducts&#x000a0;develop lateral and parallel to the Wolffian ducts at the cranial end. At the caudal end, the ducts cross ventrally, resulting in a location internal to the mesonephric duct. Next, the&#x000a0;M&#x000fc;llerian surface epithelium (MSE) invaginates and proliferates caudally in the mesenchyme between the coelomic epithelium and Wolffian ducts; this forms the&#x000a0;M&#x000fc;llerian duct mesenchyme (MDM). Then, the invaginating MSE fuses with the Wolffian ducts to form the&#x000a0;M&#x000fc;llerian duct epithelium (MDE), a canalized tube that will proliferate and migrate in a craniocaudal direction.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r5">[5]</xref></p>
        <p>Around six weeks post-fertilization, the terminal ends from both&#x000a0;M&#x000fc;llerian ducts make contact and fuse to form&#x000a0;the uterovaginal duct. This duct&#x000a0;later develops into the fornix of the vagina. Later,&#x000a0;the basement membrane of the two&#x000a0;M&#x000fc;llerian ducts fuse. Around ten weeks post-fertilization, the basement membranes&#x000a0;of the two&#x000a0;M&#x000fc;llerian ducts disappear, creating the uterus. At this time, a septum separates the primordial uterine cavity into two, each derived from one of the&#x000a0;paired M&#x000fc;llerian ducts. The uterine septum represents the fusion site of the&#x000a0;M&#x000fc;llerian ducts and is typically resorbed through apoptosis later in development. The BCL2 gene&#x000a0;appears to regulate this process in humans. The distal end of the uterovaginal duct contacts the posterior wall of the urogenital sinus resulting in the&#x000a0;M&#x000fc;llerian tubercle. Further, after the fusion of the distal ducts, the broad ligament of the uterus is formed by an extension of peritoneal folds&#x000a0;and connects the pelvic walls to the fused&#x000a0;M&#x000fc;llerian ducts. The cranial end of the uterovaginal duct becomes the abdominal ostium of the fallopian tubes. The hymen appears to be formed by the urogenital sinus and the&#x000a0;M&#x000fc;llerian ducts.<xref ref-type="bibr" rid="article-25337.r5">[5]</xref><xref ref-type="bibr" rid="article-25337.r6">[6]</xref><xref ref-type="bibr" rid="article-25337.r7">[7]</xref><xref ref-type="bibr" rid="article-25337.r3">[3]</xref><xref ref-type="bibr" rid="article-25337.r8">[8]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-25337.s3" sec-type="Cellular">
        <title>Cellular</title>
        <p>Based on&#x000a0;immunohistochemical&#x000a0;studies of mice, the incipient M&#x000fc;llerian ducts initially form as&#x000a0;mesoepithelial tubes that later differentiate into epithelial tubes<xref ref-type="bibr" rid="article-25337.r3">[3]</xref>. They are derived from intermediate mesoderm&#x000a0;and composed of both epithelial and mesenchymal cells. The&#x000a0;M&#x000fc;llerian ducts develop&#x000a0;as a result of the formation of three distinct tissue layers: M&#x000fc;llerian surface epithelium (MSE), M&#x000fc;llerian duct mesenchyme (MDM), and M&#x000fc;llerian duct epithelium (MDE). The M&#x000fc;llerian surface epithelium is the outermost layer. The M&#x000fc;llerian duct mesenchyme is the&#x000a0;middle layer. The M&#x000fc;llerian duct epithelium is the innermost layer that lines the internal aspect of the duct. This internal epithelium expresses a mesenchymal marker&#x000a0;early in development but does not express typical or true epithelium markers (e.g., cadherin 1) until later in embryonic development.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r5">[5]</xref></p>
      </sec>
      <sec id="article-25337.s4" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>The interaction between the epithelium and the mesenchyme regulates transcription factors and signaling molecules necessary for developing the&#x000a0;M&#x000fc;llerian ducts. Some transcription factors likely part of this human developmental process include <italic toggle="yes">EMX2, HOXA13, PAX2, LIM1</italic>, and WNT<italic toggle="yes">.</italic>
<italic toggle="yes">Lim1(Lhx1)</italic> and <italic toggle="yes">Pax2</italic> are essential in specifying the&#x000a0;M&#x000fc;llerian duct precursor cells in mouse studies. Specifically, <italic toggle="yes">Lim1</italic> is necessary for forming the&#x000a0;M&#x000fc;llerian duct epithelium, and without <italic toggle="yes">Lim1</italic>, agenesis of the&#x000a0;M&#x000fc;llerian ducts occurs in mice. Also, from mouse studies, loss of <italic toggle="yes">Pax2</italic> results in the absence of the kidneys and agenesis of the reproductive tract due to the loss of the Wolffian and&#x000a0;M&#x000fc;llerian ducts. In studies of chickens,&#x000a0;<italic toggle="yes">Bmp/PAX2</italic> and <italic toggle="yes">Fdf/LIM1</italic> signaling regulate the initiation phase of&#x000a0;M&#x000fc;llerian duct formation and are also necessary for specification.<xref ref-type="bibr" rid="article-25337.r9">[9]</xref>&#x000a0;</p>
        <p><italic toggle="yes">Bmp</italic>&#x000a0;signaling occurs in the cranial mesonephros and begins the expression of <italic toggle="yes">PAX2</italic> in the M&#x000fc;llerian duct mesenchyme.&#x000a0;It appears that cells with <italic toggle="yes">PAX2</italic> are pre-specified&#x000a0;M&#x000fc;llerian duct precursor cells. <italic toggle="yes">Emx2</italic> appears necessary for the formation of the&#x000a0;M&#x000fc;llerian and Wolffian ducts in mouse studies.<xref ref-type="bibr" rid="article-25337.r10">[10]</xref> Additionally, combination mutations in retinoic acid have&#x000a0;produced malformations of the caudal portion of the reproductive tract. Invagination is also regulated by fibroblast growth factor (Fgf).<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r11">[11]</xref></p>
        <p><italic toggle="yes">WNT</italic>&#x000a0;and <italic toggle="yes">HOX</italic>&#x000a0;gene expression&#x000a0;appear to be&#x000a0;crucial for the development of the&#x000a0;M&#x000fc;llerian ducts in humans. Animal studies have shown that a lack of <italic toggle="yes">Wnt7a </italic>leads to abnormal female reproductive tracts, as it is required for sexual dimorphic differentiation. Typical findings of <italic toggle="yes">Wnt7a</italic> dysfunction in animal studies include the development of a small, thin uterus that lacks typical uterine glands. In addition, the function of <italic toggle="yes">Wnt7a</italic> during embryonic development of the&#x000a0;M&#x000fc;llerian ducts is to maintain the expression of <italic toggle="yes">Hoxa10</italic> and <italic toggle="yes">Hoxa11</italic>. The expression of these two genes is&#x000a0;critical for developing the&#x000a0;M&#x000fc;llerian ducts in animal studies. <italic toggle="yes">Hoxa10</italic>&#x000a0;also contributes to the development of the M&#x000fc;llerian ducts as it determines the borders of tissues of the reproductive tract. Differentiation of the&#x000a0;M&#x000fc;llerian ducts into structures of the female genitalia is also regulated by <italic toggle="yes">Hoxa</italic> genes in animal studies, specifically <italic toggle="yes">Hoxa9, Hoxa10, Hoxa11, and Hoxa13. Wnt4</italic> and <italic toggle="yes">Wnt5a</italic> have also shown importance to the&#x000a0;M&#x000fc;llerian ducts during later development.&#x000a0;Moreover, the absence of&#x000a0;<italic toggle="yes">Wnt4</italic> causes abnormal uterine morphology, while the absence of&#x000a0;<italic toggle="yes">Wnt5a</italic> causes disruptions in the differential of the&#x000a0;M&#x000fc;llerian Ducts caudally.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r11">[11]</xref><xref ref-type="bibr" rid="article-25337.r12">[12]</xref></p>
        <p>The precursor cells of the&#x000a0;M&#x000fc;llerian ducts express <italic toggle="yes">Lim1,</italic>&#x000a0;a homeodomain transcription factor. <italic toggle="yes">Lim1</italic> is essential for the formation and maintenance of the female reproductive tract. Missense mutations of <italic toggle="yes">Lim1</italic> have been shown to result in agenesis of the&#x000a0;M&#x000fc;llerian ducts in mouse studies. More recent specific studies have indicated that Lim1 is essential for elongating the&#x000a0;M&#x000fc;llerian ducts, and loss of this gene leads to shortened fallopian tubes, aplasia of the uterus, and infertility.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r12">[12]</xref></p>
        <p>The influence of Wolffian ducts significantly affects the later stage of development of the&#x000a0;M&#x000fc;llerian ducts. The association of these two structures is required for the correct elongation of the&#x000a0;M&#x000fc;llerian ducts, while specification and invagination are independent of these structures. The influence of the Wolffian ducts contributes to the elongation of the&#x000a0;M&#x000fc;llerian ducts. This process occurs through the secretion of a local signaling molecule that induces&#x000a0;M&#x000fc;llerian duct cell proliferation. <italic toggle="yes">WNT9B</italic>&#x000a0;in humans is a Wolffian duct-derived factor considered necessary for the elongation of the&#x000a0;M&#x000fc;llerian ducts. Further, researchers have observed the&#x000a0;M&#x000fc;llerian duct to elongate through the proliferation and active migration of the M&#x000fc;llerian duct epithelium. These proliferating cells are located at the tip of the M&#x000fc;llerian duct epithelium and have a high proliferation index. This elongation uses the phosphatidylinositol 3-kinase signaling pathway, which is typically activated by tyrosine-kinase receptors.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref></p>
      </sec>
      <sec id="article-25337.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Anomalies in the female reproductive tract are estimated to be&#x000a0;present in 0.1 to 3.0% of live births. Because the&#x000a0;M&#x000fc;llerian ducts originate from the same intermediate mesoderm as the mesonephros, any female reproductive tract anomaly should warrant investigation of renal anomalies. The typical investigation of&#x000a0;M&#x000fc;llerian duct anomalies starts with a physical exam, although this&#x000a0;is often unrevealing. Imaging should also be evaluated with the initial imaging modality&#x000a0;by pelvic ultrasound. Further investigation can be completed with an MRI, hysterosalpingography, or laparoscopy. Numerous uterine anomalies&#x000a0;can be classified, in addition to&#x000a0;conditions&#x000a0;resulting from failure in developing the&#x000a0;M&#x000fc;llerian ducts.<xref ref-type="bibr" rid="article-25337.r11">[11]</xref><xref ref-type="bibr" rid="article-25337.r6">[6]</xref><xref ref-type="bibr" rid="article-25337.r7">[7]</xref><xref ref-type="bibr" rid="article-25337.r2">[2]</xref></p>
        <p>
<bold>Class I: Uterine Agenesis/Hypoplasia</bold>
</p>
        <p>Uterine agenesis and hypoplasia are due to early developmental dysfunction of the&#x000a0;M&#x000fc;llerian ducts around five weeks of gestation. This anomaly&#x000a0;accounts for 5&#x000a0;to 10% of all uterine abnormalities. Uterine agenesis is defined as no identifiable uterus or the presence&#x000a0;of solely rudimentary tissue. This&#x000a0;may present in an individual as primary amenorrhea with normal secondary sex characteristics during puberty due to fully developed ovaries. In uterine hypoplasia, there is a small but fully differentiated uterus.<xref ref-type="bibr" rid="article-25337.r13">[13]</xref></p>
        <p>The most common form of uterine agenesis is Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH). MRKH is an autosomal dominant condition with incomplete penetrance and variable expressivity. The incidence of MRKH has been estimated to be 1 in 4500 female births. It is defined as agenesis of the uterus, cervix, and upper 1/3 of the vagina. Among the agenesis of these parts of the reproductive tract, individuals with MRKH can also have skeletal, renal, cardiac, auditory, and digital anomalies. There are two types of MRKH. Type 1 has agenesis of the uterus with two rudimentary horns and normal fallopian tubes. Type 2 is defined by either symmetric or asymmetric hypoplasia of the uterus with aplasia of one of the two horns and fallopian tube malformations.<xref ref-type="bibr" rid="article-25337.r13">[13]</xref><xref ref-type="bibr" rid="article-25337.r14">[14]</xref></p>
        <p>
<bold>Class II: Unicornuate Uterus</bold>
</p>
        <p>This condition is due to the arrest of the development of one of the&#x000a0;M&#x000fc;llerian ducts. This anomaly accounts for 20% of all uterine anomalies. There are four different subtypes of the unicornuate uterus: absent rudimentary horn, non-cavitary rudimentary horn, cavitary communicating horn, and cavitary non-communicating rudimentary horn. The cavitary non-communicating rudimentary horn can cause obstruction, potentially resulting in abdominal pain and ultimately needing surgical intervention. Abnormal fetal presentation and intrauterine growth retardation are common obstetrical problems.<xref ref-type="bibr" rid="article-25337.r13">[13]</xref><xref ref-type="bibr" rid="article-25337.r6">[6]</xref></p>
        <p>
<bold>Class III: Didelphys Uterus</bold>
</p>
        <p>Didelphys uterus is due to failure of fusion of the&#x000a0;M&#x000fc;llerian ducts to form the uterus and accounts for 5% of uterine anomalies. In a&#x000a0;didelphic uterus, each of the uterine horns fully develops due to the complete non-fusion of the&#x000a0;M&#x000fc;llerian ducts. Two crevices are present, and there is a deep fundal cleft. There can also be a transverse or longitudinal vaginal septum. There is no communication between the two uteruses. Spontaneous abortion and premature birth both increase due to this anomaly.<xref ref-type="bibr" rid="article-25337.r13">[13]</xref><xref ref-type="bibr" rid="article-25337.r6">[6]</xref></p>
        <p>
<bold>Class IV: Bicornuate Uterus</bold>
</p>
        <p>A bicornuate uterus is due to the incomplete fusion of the&#x000a0;M&#x000fc;llerian ducts. It is present in 10% of all uterine anomalies. This causes central myometrium, which can extend to the internal or external cervical os. A septum that extends to make two cervixes is called a bicornuate bicollis uterus. The depth of the fundal cleft is greater than 1 cm. The horns are less functional in a bicornuate uterus than in a&#x000a0;didelphic uterus. Studies have shown little effect of the bicornuate uterus on obstetrical outcomes; however, there are better outcomes for a partial bicornuate uterus than a complete one. Research has found the bicornuate uterus has the highest cervical incompetence rate among the&#x000a0;M&#x000fc;llerian duct anomalies. Problems may present at menarche if an obstructive uterus didelphys is present. Pelvic adhesions and endometriosis are more prevalent in obstructive anomalies.<xref ref-type="bibr" rid="article-25337.r13">[13]</xref><xref ref-type="bibr" rid="article-25337.r6">[6]</xref><xref ref-type="bibr" rid="article-25337.r2">[2]</xref></p>
        <p>
<bold>Class V: Septate Uterus</bold>
</p>
        <p>Septate uterus is the most common uterine anomaly, comprising 55% of anomalies. It is due to defective resorption of the fibrous septum between the two&#x000a0;M&#x000fc;llerian ducts. The uterus divides into two cavities because of this septum. The septum can be composed of muscle, fibrous tissue, or both. Septate uteruses have the poorest obstetrical outcomes, with spontaneous abortion rates of up to 94% and premature birth rates of up to 33%. The treatment for the septate uterus is a surgical intervention to remove the septum.<xref ref-type="bibr" rid="article-25337.r13">[13]</xref><xref ref-type="bibr" rid="article-25337.r6">[6]</xref></p>
        <p>
<bold>Class VI: Arcuate Uterus</bold>
</p>
        <p>An arcuate uterus is due to the indention of the endometrium into the uterine fundus. An arcuate uterus is due to the near-complete but not total resorption of the uterine septum. There is limited data on the effect of an arcuate uterus on the obstetrical outcome.<xref ref-type="bibr" rid="article-25337.r13">[13]</xref><xref ref-type="bibr" rid="article-25337.r6">[6]</xref></p>
        <p>
<bold>Class VII: Diethylstilbestrol (DES) Exposure</bold>
</p>
        <p>DES is a nonsteroidal estrogen analog that causes altered Hox gene expression in the&#x000a0;M&#x000fc;llerian Ducts. DES affects newborn girls after their mothers use DES to prevent miscarriage. However, the research found that DES caused uterine malformations and increased the risk of vaginal clear cell carcinoma. Studies have shown that 69% of women exposed to DES have uterine anomalies. The typical uterine malformations include a hypoplastic uterus, a T-shaped uterine cavity (31%), abnormal transverse ridges and hoods, and cervical anomalies (44%). There is an associated two-times increased risk of spontaneous abortion and a nine-fold increased risk of ectopic pregnancy for women exposed to DES. Further, there is an association with DES and an increase in premature labor and cervical incompetence.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r13">[13]</xref><xref ref-type="bibr" rid="article-25337.r6">[6]</xref></p>
        <p>
<bold>Gartner Duct</bold>
</p>
        <p>The Gartner duct is a remnant of the Wolffian duct; this can become a cystic structure in the lower wall of the vagina and is known as the Gartner&#x02019;s cyst.<xref ref-type="bibr" rid="article-25337.r5">[5]</xref></p>
        <p>
<bold>Congenital anomalies of the Fallopian Tubes</bold>
</p>
        <p>These rare anomalies are typically agenesis, hypoplasia, or segmental narrowing of the fallopian tubes.<xref ref-type="bibr" rid="article-25337.r6">[6]</xref></p>
        <p>
<bold>Transverse Vaginal Septum</bold>
</p>
        <p>A transverse vaginal septum is present when there is a defect in the canalization of the vaginal plaque at the location of the urogenital sinus meeting the&#x000a0;M&#x000fc;llerian duct. Variations are present in this type of septum, including perforation. A perforated transverse vaginal septum typically causes fewer symptoms as the patient can menstruate. The location of the septum determines the severity and treatment. The easiest to treat is the transverse septum which is thin, located low, and perforated. The most difficult is&#x000a0;a high and thick septum. This type can present with a rectovaginal fistula and require a hysterectomy.<xref ref-type="bibr" rid="article-25337.r7">[7]</xref></p>
        <p>
<bold>Hand-Foot-Genital Syndrome (HFG)</bold>
</p>
        <p>HFG is an autosomal dominant condition due to mutations in the Hoxa13 gene. Patients with this disorder have shortened thumbs, great toes, and a bicornuate or didelphys uterus.<xref ref-type="bibr" rid="article-25337.r11">[11]</xref></p>
        <p>
<bold>Persistent&#x000a0;M&#x000fc;llerian Duct Syndrome (PMDS)</bold>
</p>
        <p>Alterations in AMH secretion, AMH gene, or AMH receptors result in retained&#x000a0;M&#x000fc;llerian ducts. Complete gonadal dysgenesis in males causes no secretion of AMH, while a mutation in the AMH gene or the AMH receptor causes abnormal function of AMH. The normal function of AMH in males is to bind to Type I and II receptors present in the MDM; this causes signal transduction via SMAD phosphorylation. Activation of the receptors results in apoptosis of the MDE in males. PMDS is an autosomal recessive disorder in males caused by a mutation in the gene coding the AMH type II receptor. There have been 38 identified mutations that can cause this syndrome. Some of the mutations cause changes to the C terminal of the receptor rendering it bio-inactive. The non-functional AMH receptor leads to the retention of the&#x000a0;M&#x000fc;llerian ducts in males. Normal findings at birth for a patient with PMDS include normal phenotype and cryptorchidism (unilateral or bilateral). The persistent&#x000a0;M&#x000fc;llerian structures are typically discovered during surgical repair of the cryptorchidism.<xref ref-type="bibr" rid="article-25337.r1">[1]</xref><xref ref-type="bibr" rid="article-25337.r15">[15]</xref><xref ref-type="bibr" rid="article-25337.r16">[16]</xref><xref ref-type="bibr" rid="article-25337.r8">[8]</xref></p>
      </sec>
      <sec id="article-25337.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25337&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25337">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25337/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25337">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25337.s7">
        <title>References</title>
        <ref id="article-25337.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roly</surname>
                <given-names>ZY</given-names>
              </name>
              <name>
                <surname>Backhouse</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cutting</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Sinclair</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Ayers</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Major</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The cell biology and molecular genetics of M&#x000fc;llerian duct development.</article-title>
            <source>Wiley Interdiscip Rev Dev Biol</source>
            <year>2018</year>
            <month>May</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>e310</fpage>
            <pub-id pub-id-type="pmid">29350886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robbins</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Broadwell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Parry</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sadowski</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>M&#x000fc;llerian duct anomalies: embryological development, classification, and MRI assessment.</article-title>
            <source>J Magn Reson Imaging</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-12</page-range>
            <pub-id pub-id-type="pmid">25288098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orvis</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Behringer</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Cellular mechanisms of M&#x000fc;llerian duct formation in the mouse.</article-title>
            <source>Dev Biol</source>
            <year>2007</year>
            <month>Jun</month>
            <day>15</day>
            <volume>306</volume>
            <issue>2</issue>
            <fpage>493</fpage>
            <page-range>493-504</page-range>
            <pub-id pub-id-type="pmid">17467685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice.</article-title>
            <source>Science</source>
            <year>2017</year>
            <month>Aug</month>
            <day>18</day>
            <volume>357</volume>
            <issue>6352</issue>
            <fpage>717</fpage>
            <page-range>717-720</page-range>
            <pub-id pub-id-type="pmid">28818950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sajjad</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Development of the genital ducts and external genitalia in the early human embryo.</article-title>
            <source>J Obstet Gynaecol Res</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>929</fpage>
            <page-range>929-37</page-range>
            <pub-id pub-id-type="pmid">20846260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Troiano</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Mullerian duct anomalies: imaging and clinical issues.</article-title>
            <source>Radiology</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>233</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-34</page-range>
            <pub-id pub-id-type="pmid">15317956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Passos</surname>
                <given-names>IMPE</given-names>
              </name>
              <name>
                <surname>Britto</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of m&#x000fc;llerian malformations.</article-title>
            <source>Taiwan J Obstet Gynecol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>183</fpage>
            <page-range>183-188</page-range>
            <pub-id pub-id-type="pmid">32127135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warne</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Kanumakala</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Molecular endocrinology of sex differentiation.</article-title>
            <source>Semin Reprod Med</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>169</fpage>
            <page-range>169-80</page-range>
            <pub-id pub-id-type="pmid">12428197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atsuta</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Early formation of the M&#x000fc;llerian duct is regulated by sequential actions of BMP/Pax2 and FGF/Lim1 signaling.</article-title>
            <source>Development</source>
            <year>2016</year>
            <month>Oct</month>
            <day>01</day>
            <volume>143</volume>
            <issue>19</issue>
            <fpage>3549</fpage>
            <page-range>3549-3559</page-range>
            <pub-id pub-id-type="pmid">27578782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pellegrini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pantano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lucchini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Forabosco</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Emx2 developmental expression in the primordia of the reproductive and excretory systems.</article-title>
            <source>Anat Embryol (Berl)</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>196</volume>
            <issue>6</issue>
            <fpage>427</fpage>
            <page-range>427-33</page-range>
            <pub-id pub-id-type="pmid">9453363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Behringer</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Developmental genetics of the female reproductive tract in mammals.</article-title>
            <source>Nat Rev Genet</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>12</issue>
            <fpage>969</fpage>
            <page-range>969-80</page-range>
            <pub-id pub-id-type="pmid">14631357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Orvis</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Behringer</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Lhx1 is required in M&#x000fc;llerian duct epithelium for uterine development.</article-title>
            <source>Dev Biol</source>
            <year>2014</year>
            <month>May</month>
            <day>15</day>
            <volume>389</volume>
            <issue>2</issue>
            <fpage>124</fpage>
            <page-range>124-36</page-range>
            <pub-id pub-id-type="pmid">24560999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chandler</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Machan</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Cooperberg</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Mullerian duct anomalies: from diagnosis to intervention.</article-title>
            <source>Br J Radiol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>82</volume>
            <issue>984</issue>
            <fpage>1034</fpage>
            <page-range>1034-42</page-range>
            <pub-id pub-id-type="pmid">19433480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morcel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Camborieux</surname>
                <given-names>L</given-names>
              </name>
              <collab>Programme de Recherches sur les Aplasies M&#x000fc;ll&#x000e9;riennes</collab>
              <name>
                <surname>Guerrier</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Mayer-Rokitansky-K&#x000fc;ster-Hauser (MRKH) syndrome.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2007</year>
            <month>Mar</month>
            <day>14</day>
            <volume>2</volume>
            <fpage>13</fpage>
            <pub-id pub-id-type="pmid">17359527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belville</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Van Vlijmen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ehrenfels</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pepinsky</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rezaie</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Josso</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>di Clemente</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cate</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model.</article-title>
            <source>Mol Endocrinol</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>708</fpage>
            <page-range>708-21</page-range>
            <pub-id pub-id-type="pmid">14673134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25337.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Josso</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Belville</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>di Clemente</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>AMH and AMH receptor defects in persistent M&#x000fc;llerian duct syndrome.</article-title>
            <source>Hum Reprod Update</source>
            <year>2005</year>
            <season>Jul-Aug</season>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>351</fpage>
            <page-range>351-6</page-range>
            <pub-id pub-id-type="pmid">15878900</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
